The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria

the 2013 revision and update

T. Zuberbier, W. Aberer, R. Asero, C. Bindslev-Jensen, Z. Brzoza, G. W. Canonica, M. K. Church, L. F. Ensina, A. Gimenez-Arnau, K. Godse, M. Goncalo, C. Grattan, J. Hebert, M. Hide, A. Kaplan, A. Kapp, A. H. A. Latiff, P. Mathelier-Fusade, M. Metz, A. Nast & 11 andre S. S. Saini, M. Sanchez-Borges, P. Schmid-Grendelmeier, F. E. R. Simons, P. Staubach, G. Sussman, E. Toubi, G. A. Vena, B. Wedi, X. J. Zhu, M. Maurer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The life-time prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).
OriginalsprogPolsk
TidsskriftPrzeglad Dermatologiczny
Vol/bind102
Udgave nummer2
Sider (fra-til)155-179
ISSN0033-2526
DOI
StatusUdgivet - 2015

Emneord

  • angioedema consensus hives urticaria wheal CHRONIC IDIOPATHIC URTICARIA QUALITY-OF-LIFE SERUM SKIN-TEST DELAYED PRESSURE URTICARIA DOSE INTRAVENOUS IMMUNOGLOBULIN ANTIIMMUNOGLOBULIN-E THERAPY RESISTANT CHRONIC URTICARIA RANDOMIZED CONTROLLED-TRIAL ULTRAVIOLET-B PHOTOTHERAPY WORLD-HEALTH-ORGANIZATION

Citer dette

Zuberbier, T. ; Aberer, W. ; Asero, R. ; Bindslev-Jensen, C. ; Brzoza, Z. ; Canonica, G. W. ; Church, M. K. ; Ensina, L. F. ; Gimenez-Arnau, A. ; Godse, K. ; Goncalo, M. ; Grattan, C. ; Hebert, J. ; Hide, M. ; Kaplan, A. ; Kapp, A. ; Latiff, A. H. A. ; Mathelier-Fusade, P. ; Metz, M. ; Nast, A. ; Saini, S. S. ; Sanchez-Borges, M. ; Schmid-Grendelmeier, P. ; Simons, F. E. R. ; Staubach, P. ; Sussman, G. ; Toubi, E. ; Vena, G. A. ; Wedi, B. ; Zhu, X. J. ; Maurer, M. / The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria : the 2013 revision and update. I: Przeglad Dermatologiczny. 2015 ; Bind 102, Nr. 2. s. 155-179.
@article{33f1c0d9813a4c23b1a3df6b096a4909,
title = "The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update",
abstract = "This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The life-time prevalence for acute urticaria is approximately 20{\%}. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).",
keywords = "angioedema consensus hives urticaria wheal CHRONIC IDIOPATHIC URTICARIA QUALITY-OF-LIFE SERUM SKIN-TEST DELAYED PRESSURE URTICARIA DOSE INTRAVENOUS IMMUNOGLOBULIN ANTIIMMUNOGLOBULIN-E THERAPY RESISTANT CHRONIC URTICARIA RANDOMIZED CONTROLLED-TRIAL ULTRAVIOLET-B PHOTOTHERAPY WORLD-HEALTH-ORGANIZATION",
author = "T. Zuberbier and W. Aberer and R. Asero and C. Bindslev-Jensen and Z. Brzoza and Canonica, {G. W.} and Church, {M. K.} and Ensina, {L. F.} and A. Gimenez-Arnau and K. Godse and M. Goncalo and C. Grattan and J. Hebert and M. Hide and A. Kaplan and A. Kapp and Latiff, {A. H. A.} and P. Mathelier-Fusade and M. Metz and A. Nast and Saini, {S. S.} and M. Sanchez-Borges and P. Schmid-Grendelmeier and Simons, {F. E. R.} and P. Staubach and G. Sussman and E. Toubi and Vena, {G. A.} and B. Wedi and Zhu, {X. J.} and M. Maurer",
note = "0",
year = "2015",
doi = "10.5114/dr.2015.51433",
language = "Polsk",
volume = "102",
pages = "155--179",
journal = "Przeglad Dermatologiczny",
issn = "0033-2526",
publisher = "Termedia sp. z o.o.",
number = "2",

}

Zuberbier, T, Aberer, W, Asero, R, Bindslev-Jensen, C, Brzoza, Z, Canonica, GW, Church, MK, Ensina, LF, Gimenez-Arnau, A, Godse, K, Goncalo, M, Grattan, C, Hebert, J, Hide, M, Kaplan, A, Kapp, A, Latiff, AHA, Mathelier-Fusade, P, Metz, M, Nast, A, Saini, SS, Sanchez-Borges, M, Schmid-Grendelmeier, P, Simons, FER, Staubach, P, Sussman, G, Toubi, E, Vena, GA, Wedi, B, Zhu, XJ & Maurer, M 2015, 'The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update', Przeglad Dermatologiczny, bind 102, nr. 2, s. 155-179. https://doi.org/10.5114/dr.2015.51433

The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria : the 2013 revision and update. / Zuberbier, T.; Aberer, W.; Asero, R.; Bindslev-Jensen, C.; Brzoza, Z.; Canonica, G. W.; Church, M. K.; Ensina, L. F.; Gimenez-Arnau, A.; Godse, K.; Goncalo, M.; Grattan, C.; Hebert, J.; Hide, M.; Kaplan, A.; Kapp, A.; Latiff, A. H. A.; Mathelier-Fusade, P.; Metz, M.; Nast, A.; Saini, S. S.; Sanchez-Borges, M.; Schmid-Grendelmeier, P.; Simons, F. E. R.; Staubach, P.; Sussman, G.; Toubi, E.; Vena, G. A.; Wedi, B.; Zhu, X. J.; Maurer, M.

I: Przeglad Dermatologiczny, Bind 102, Nr. 2, 2015, s. 155-179.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria

T2 - the 2013 revision and update

AU - Zuberbier, T.

AU - Aberer, W.

AU - Asero, R.

AU - Bindslev-Jensen, C.

AU - Brzoza, Z.

AU - Canonica, G. W.

AU - Church, M. K.

AU - Ensina, L. F.

AU - Gimenez-Arnau, A.

AU - Godse, K.

AU - Goncalo, M.

AU - Grattan, C.

AU - Hebert, J.

AU - Hide, M.

AU - Kaplan, A.

AU - Kapp, A.

AU - Latiff, A. H. A.

AU - Mathelier-Fusade, P.

AU - Metz, M.

AU - Nast, A.

AU - Saini, S. S.

AU - Sanchez-Borges, M.

AU - Schmid-Grendelmeier, P.

AU - Simons, F. E. R.

AU - Staubach, P.

AU - Sussman, G.

AU - Toubi, E.

AU - Vena, G. A.

AU - Wedi, B.

AU - Zhu, X. J.

AU - Maurer, M.

N1 - 0

PY - 2015

Y1 - 2015

N2 - This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The life-time prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).

AB - This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The life-time prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).

KW - angioedema consensus hives urticaria wheal CHRONIC IDIOPATHIC URTICARIA QUALITY-OF-LIFE SERUM SKIN-TEST DELAYED PRESSURE URTICARIA DOSE INTRAVENOUS IMMUNOGLOBULIN ANTIIMMUNOGLOBULIN-E THERAPY RESISTANT CHRONIC URTICARIA RANDOMIZED CONTROLLED-TRIAL ULTRAVI

U2 - 10.5114/dr.2015.51433

DO - 10.5114/dr.2015.51433

M3 - Tidsskriftartikel

VL - 102

SP - 155

EP - 179

JO - Przeglad Dermatologiczny

JF - Przeglad Dermatologiczny

SN - 0033-2526

IS - 2

ER -